Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Cobblestone Capital Advisors LLC NY

Cobblestone Capital Advisors LLC NY increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,340 shares of the medical equipment provider’s stock after buying an additional 114 shares during the period. Cobblestone Capital Advisors LLC NY’s holdings in Intuitive Surgical were worth $658,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. Massmutual Trust Co. FSB ADV grew its holdings in Intuitive Surgical by 13.8% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 1,058 shares of the medical equipment provider’s stock valued at $471,000 after buying an additional 128 shares during the period. City State Bank raised its stake in Intuitive Surgical by 15.2% during the second quarter. City State Bank now owns 228 shares of the medical equipment provider’s stock worth $101,000 after purchasing an additional 30 shares during the period. Mather Group LLC. boosted its holdings in shares of Intuitive Surgical by 49.7% in the 2nd quarter. Mather Group LLC. now owns 2,371 shares of the medical equipment provider’s stock valued at $1,055,000 after purchasing an additional 787 shares during the last quarter. Fragasso Financial Advisors Inc grew its stake in shares of Intuitive Surgical by 12.1% during the 2nd quarter. Fragasso Financial Advisors Inc now owns 613 shares of the medical equipment provider’s stock valued at $273,000 after buying an additional 66 shares during the period. Finally, Trust Co. of Vermont increased its holdings in shares of Intuitive Surgical by 8.8% during the 2nd quarter. Trust Co. of Vermont now owns 5,049 shares of the medical equipment provider’s stock worth $2,246,000 after buying an additional 410 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $542.00 on Monday. The firm has a fifty day moving average of $510.03 and a two-hundred day moving average of $469.49. The firm has a market cap of $193.05 billion, a P/E ratio of 87.14, a P/E/G ratio of 5.33 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have commented on ISRG. Leerink Partners upped their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Piper Sandler reissued an “overweight” rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $526.06.

Insider Buying and Selling

In other news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the sale, the general counsel now directly owns 1,595 shares of the company’s stock, valued at approximately $757,625. This represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,459 shares of company stock worth $26,080,251 over the last ninety days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.